1 High-Risk Penny Stock That May Be Worth Buying
Penny stocks, or stocks with a sub-$5 share price, generally aren't my cup of tea. These types of companies tend to be far too risky to make them worthy of serious investment consideration. The oncology specialist Geron (NASDAQ: GERN), however, has piqued my interest of late -- even though the company's share price is presently hovering around $2.
While I fully admit that there are a couple of solid reasons to fear that thus speculative biotech could well end up going bankrupt, the stock's monstrous upside potential has my full attention ahead of what could be a major clinical update at the American Society of Hematology meeting later this month. So without further ado, here's why I think this penny stock may be worth buying right now.
Image Source: Getty Images.
Source: Fool.com
Geron Corp. Stock
With 16 Buy predictions and not the single Sell prediction the community is currently very high on Geron Corp..
With a target price of 5 € there is a slightly positive potential of 12.44% for Geron Corp. compared to the current price of 4.45 €.